Platelet Activating Factor Stability in Urine
Completed
Conditions studied: Interstitial Cystitis
In brief
The investigator's hypothesis is that smoking induces inflammation in the bladder wall. This may predispose to the development of Interstitial cystitis(IC) / bladder pain syndrome(BPS). Previous research has linked one the Platelet Activating Factor - PAF to interstitial cystitis. The investigators will study a limited number of patients to determine whether PAF is stable in urine and whether special precautions (for example - immediate freezing in liquid nitrogen) is necessary for accurate measurement of PAF in the urine. Patients who are presenting for an office visit will be asked to donate at least 50 ml of urine. A separate group of patients who are scheduled for surgery, are also being asked to donate around 25 ml of urine during surgery. No patient data other than group assignment, whether they smoke or if they have or not have interstitial cystitis will be recorded.
Key facts
- Study ID
- NCT03103477
- Run by
- St. Louis University
- People needed
- 16
- Starts
- 2017-01-27
- Expected to finish
- 2017-02-28
- Last updated by the study team
- 2018-07-18
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patient presenting for routine care in the UroGynecology division or
- Patient undergoing gynecologic or urogynecologic surgery exceeding 60 minute operating time.
You may not qualify if…
- Age less than 18 or more than 80
- Unable to provide informed consent
Where it is running
- St. Mary's Health Center — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.